Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Premier Biosoft Enter Reselling Agreement for SimLipid, SimMet Software

NEW YORK(GenomeWeb) – Premier Biosoft and Bruker said today that they have entered a reselling agreement under which Bruker will co-market and resell Premier's SimLipid and SimMet informatics software. 

SimLipid and SimMet are intended for mass spec-based analysis of, respectively, lipids and metabolites and facilitate automated LC-MS and MS/MS data processing workflows and identification and quantitation of these analytes, the companies said.

"With this collaboration, we hope to address several of the challenges in advanced biomarker and translational research," Aiko Barsch, market manager at Bruker, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.